Assawasaksakul Theerada, Boonsarngsuk Viboon, Incharoen Pimpin
Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Department of Pathology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
J Thorac Dis. 2017 Sep;9(9):3161-3167. doi: 10.21037/jtd.2017.08.52.
In a patient with pleural effusion, cytological study (CS) is one of the most useful investigations, especially when malignancy is suspected. Instead of applying only CS, the pleural fluid can be further processed using the cell block (CB) technique, which may augment the diagnostic utility. The aim of this study was to compare the diagnostic yields of CS, CB, and the combination of both, regardless of the etiology of pleural effusion.
A cross-sectional study was conducted on patients with pleural effusions who underwent thoracentesis from June 2015 to May 2016. All samples were submitted for routine biochemical analysis, CS, and CB histology. The results of cytopathological studies were compared to the final diagnoses.
Out of a total of 353 samples, the final diagnoses included 278 (78.8%) malignancies, 41 (11.6%) infectious diseases, 16 (4.5%) other inflammatory diseases, and 18 (5.1%) transudative pleural effusions. CS and CB provided a similar diagnostic yield (48.7% . 49.9%, P=0.69), while the combination of both gave a higher yield (57.2%) (P<0.001, compared with CS). Among 278 malignant pleural effusions (MPE), the diagnostic yields of CS and CB were 61.2% and 61.9%, respectively. Combined CS and CB improved the diagnostic yield to 71.2% (P<0.001). However, both CS and CB had low diagnostic yields in infectious pleuritis, other inflammatory diseases, and transudative pleural effusions.
In MPE, CB provides a similar diagnostic performance to CS, while application of both techniques can significantly increase the diagnostic yield. However, in other pleural diseases, CB and CS had limited values in diagnosis.
对于胸腔积液患者,细胞学检查(CS)是最有用的检查方法之一,尤其是在怀疑为恶性肿瘤时。除了单纯应用CS外,胸腔积液还可采用细胞块(CB)技术进一步处理,这可能会提高诊断效用。本研究的目的是比较CS、CB以及两者联合应用的诊断率,而不考虑胸腔积液的病因。
对2015年6月至2016年5月接受胸腔穿刺术的胸腔积液患者进行了一项横断面研究。所有样本均进行常规生化分析、CS和CB组织学检查。将细胞病理学研究结果与最终诊断结果进行比较。
在总共353份样本中,最终诊断包括278例(78.8%)恶性肿瘤、41例(11.6%)感染性疾病、16例(4.5%)其他炎症性疾病和18例(5.1%)漏出性胸腔积液。CS和CB的诊断率相似(48.7%对49.9%,P = 0.69),而两者联合应用的诊断率更高(57.2%)(与CS相比,P < 0.001)。在278例恶性胸腔积液(MPE)中,CS和CB的诊断率分别为61.2%和61.9%。CS和CB联合应用可将诊断率提高至71.2%(P < 0.001)。然而,CS和CB在感染性胸膜炎、其他炎症性疾病和漏出性胸腔积液中的诊断率均较低。
在MPE中,CB的诊断性能与CS相似,而两种技术联合应用可显著提高诊断率。然而,在其他胸腔疾病中,CB和CS的诊断价值有限。